"Our popular AxSYM system continues to support the busy needs of medium-sized laboratories. These three assays add value to this system and demonstrate our commitment to further expanding AxSYM's diagnostic menu in the U.S.," said Michael J. Collins, vice president, U.S. Diagnostic Commercial Operations, Abbott Laboratories.
"Endocrine disorders often go undiagnosed. Patients and their doctors may attribute symptoms such as fatigue or weight fluctuation to lifestyle or aging factors. This is particularly the case with thyroid disorders, which are estimated to affect 27 million Americans. Among those with an over- or under-active thyroid, more than half still remain undiagnosed," said Paul W. Ladenson, M.D., Professor of Medicine and Director of Endocrinology and Metabolism at Johns Hopkins.
"With our AxSYM system, a laboratory can process a variety of immunodiagnostic tests simultaneously," said William Brown, Ph.D., vice president, Diagnostic Assays and Systems Development, Abbott Laboratories. "Within the endocrinology menu, the Anti-TPO and Anti-Tg assays are sensitive, precise and results are ready within 19 minutes. Our Cortisol assay is also sensitive, features good precision across the range, and provides results within 12 minutes."
The AxSYM immunoassay system can process up to 80 to 120 tests per hour. Besides endocrinology, other test menus include assays for abused drugs, cancer, cardiac, fertility, hepatitis, infectious disease, metabolic/renal, therapeutic drug monitoring and toxicology.
About Abbott Laboratories
Abbott Laboratories is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceutical and medical products, including nutritionals, devices and diagnostics. The company employs more than 55,000 people and markets its products in more than 130 countries.
abbott
Recommendations:
• Buy Urimax F without Prescription
No hay comentarios:
Publicar un comentario